Transplantation-associated thrombotic microangiopathy (TA-TMA) is a serious complication
of hematopoietic stem cell transplantation (HSCT). We characterized the incidence, risk …

Transplantation‐associated thrombotic microangiopathy (TA‐TMA) is a significant
complication of haematopoietic stem cell transplantation. However, it remains controversial …

Transplant-associated thrombotic microangiopathy (TA-TMA) is a fatal complication of
allogeneic hematopoietic stem cell transplantation (allo-HSCT). However, so far, no large …

Transplant‐associated thrombotic microangiopathy (TA‐TMA) has a wide range of
presentations after hematopoietic stem‐cell transplantation (HSCT). We retrospectively …

Transplantation-associated thrombotic microangiopathy (TA-TMA) is an increasingly
recognized complication of hematopoietic cell transplantation (HCT) associated with …

Transplant-associated thrombotic microangiopathy (TMA) leads to generalized endothelial
dysfunction that can progress to multiorgan injury, and severe cases are associated with …

Hematopoietic stem cell transplantation-associated thrombotic microangiopathy (HSCT-
TMA) is a serious complication of the transplantation process that has been consistently …

Transplant‐associated thrombotic microangiopathy (TA‐TMA) is a complication of
allogeneic transplantation (allo‐HCT). The incidence and risk factors associated with TA …

Transplant-associated thrombotic microangiopathy (TA-TMA) is a potentially life-threatening
complication following allogeneic hematopoietic stem cell transplantation (allo-HSCT) …

Background. Thrombotic microangiopathy (TMA) has been described as severe
complication after hematopoietic stem cell transplantation (HSCT). The principal aim of this …